CRUK Lung Cancer Centre of Excellence
In research, CRUK Lung Cancer Centre of Excellence stands highest in Life Sciences (#1,772 of 7,800 worldwide), Medicine (#3,463 of 10,443 worldwide) and Health Sciences (#4,805 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Oncology — Oncology is 13.0× its share of world research.
- World rank, 2022–2025
- #3,929 of 28,054 · #4,829 all time
- Rank in United Kingdom
- #158 of 1,094
- Research works
- 650 ▲ 12% vs 2013–17
- Citations
- 35k 54.1 per fractional work
- Top-10% rate
- 29.1% record average 16.5%
- Open access
- 66% world 28%
What is CRUK Lung Cancer Centre of Excellence known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| Life SciencesDomain | #1,772 of 7,800 | 31.9% | 65 | #2084 | |
| MedicineField | #3,463 of 10,443 | 26.8% | 95 | #3340 | |
| Health SciencesDomain | #4,805 of 11,982 | 26.6% | 96 | #4612 |
Each strip is that field’s whole ranked pool, with the notch where CRUK Lung Cancer Centre of Excellence sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Which of those standings moved
The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.
- Life Sciences#2,084 #1,772
- Medicine#3,340 #3,463
- Health Sciences#4,612 #4,805
A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.
What does CRUK Lung Cancer Centre of Excellence specialise in?
Where its research is concentrated relative to its size: Oncology takes 13.0× the share of its output that it takes of world research.
- OncologySubfield · 25.7 works13×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 7.8×. Every wedge is a field page.
- Immunology and Microbiology 7.8×
- Biochemistry, Genetics and Molecular Biology 5.2×
- Medicine 2.8×
- Mathematics 0.6×
- Neuroscience 0.5×
- Chemistry 0.5×
- Dentistry 0.3×
- Economics, Econometrics and Finance 0.3×
- Computer Science 0.3×
- Decision Sciences 0.2×
- Health Professions 0.2×
- Nursing 0.2×
- Veterinary 0.2×
- Psychology 0.2×
- Physics and Astronomy 0.1×
- Materials Science 0.1×
- Energy 0.1×
- Environmental Science 0.1×
- Agricultural and Biological Sciences 0.1×
- Chemical Engineering 0.1×
- Engineering 0.1×
- Social Sciences 0.1×
- Business, Management and Accounting 0.0×
Which keywords describe research at CRUK Lung Cancer Centre of Excellence?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Targeted Therapy, Immunotherapy, Chemotherapy, Genomic Instability, Prognostic Factors, Cell-Free DNA, Cancer Genomics and Mutational Signatures.
- DNA Methylation
- Tumor Staging
- Treatment Guidelines
- EGFR Mutations
- Antigen Presentation
- Cell Death
- Innate Immunity
- Genetic Mutations
- Immune Checkpoint Blockade
- Genomic Profiling
- CAR T Cells
- Radiotherapy
- Cancer Therapy
- Lymphoma
- Tumor Microenvironment
- Cancer Immunotherapy
- Cancer Genomics
- Prognostic Factors
- Genomic Instability
- Immunotherapy
- Targeted Therapy
- Chemotherapy
- Cell-Free DNA
- Cancer
- Mutational Signatures
- Clinical Trials
- Biomarkers
- Tumor Regression
- Gene Expression
- Leukemia
- Chimeric Antigen Receptor
- Immunity
- PD-1 and PD-L1
- Precision Medicine
- Metastasis
- Minimal Residual Disease
- ALK Inhibitors
- Prostate Cancer
- Epigenetic Reprogramming
- Adjuvant Therapy
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Targeted Therapy16▲ 41×4 topics
- Immunotherapy16▲ 13×17 topics
- Chemotherapy13▲ 11×21 topics
- Genomic Instability11▲ 57×3 topics
- Cell-Free DNA11▲ 61×2 topics
- Prognostic Factors11▲ 14×14 topics
- Cancer10▲ 4.5×37 topics
- Cancer Genomics10▲ 82×1 topic
- Mutational Signatures10▲ 82×1 topic
- Cancer Immunotherapy10▲ 38×3 topics
- Clinical Trials10▲ 8.3×10 topics
- Tumor Microenvironment9▲ 12×7 topics
- Biomarkers8▲ 6.3×11 topics
- Lymphoma8▲ 26×3 topics
- Tumor Regression7▲ 36×2 topics
- Cancer Therapy7▲ 6.6×13 topics
- Gene Expression6▲ 6.1×13 topics
- Radiotherapy6▲ 9.5×12 topics
- Leukemia6▲ 43×2 topics
- CAR T Cells6▲ 47×1 topic
- Chimeric Antigen Receptor6▲ 47×1 topic
- Genomic Profiling6▲ 33×2 topics
- Immunity6▲ 8.3×9 topics
- Immune Checkpoint Blockade5▲ 28×1 topic
- PD-1 and PD-L15▲ 28×1 topic
- Genetic Mutations5▲ 6.8×12 topics
- Precision Medicine5▲ 5.7×8 topics
- Innate Immunity5▲ 8.2×9 topics
- Metastasis4▲ 7.5×12 topics
- Cell Death4▲ 11×6 topics
- Minimal Residual Disease4▲ 35×2 topics
- Antigen Presentation4▲ 26×2 topics
- ALK Inhibitors4▲ 34×1 topic
- EGFR Mutations4▲ 34×1 topic
- Prostate Cancer4▲ 17×4 topics
- Treatment Guidelines4▲ 10×2 topics
- Epigenetic Reprogramming4▲ 22×2 topics
- Tumor Staging4▲ 18×2 topics
- Adjuvant Therapy4▲ 16×2 topics
- DNA Methylation4▲ 18×3 topics
Which research topics does CRUK Lung Cancer Centre of Excellence publish most on?
By volume in 2022–2025: Cancer Genomics and Diagnostics, CAR-T cell therapy research, Cancer Immunotherapy and Biomarkers and Lung Cancer Treatments and Mutations.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer Genomics and Diagnostics Cancer Research 10 works
- 2 CAR-T cell therapy research Oncology 6 works
- 3 Cancer Immunotherapy and Biomarkers Oncology 5 works
- 4 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 4 works
- 5 Immunotherapy and Immune Responses Immunology 3 works
- 6 Epigenetics and DNA Methylation Molecular Biology 3 works
- 7 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 3 works
- 8 Immune Cell Function and Interaction Immunology 3 works
- 9 T-cell and B-cell Immunology Immunology 3 works
- 10 Cancer Cells and Metastasis Oncology 2 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has CRUK Lung Cancer Centre of Excellence's research output changed?
Output in 2018–2022 was 12% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Manchester
- University of Manchester
- Manchester Metropolitan University
- Manchester Royal Infirmary
- Manchester Academic Health Science Centre
- The Christie Hospital
- Manchester University NHS Foundation Trust
- Cancer Research UK Manchester Institute
- Wythenshawe Hospital
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.